$PLX SEC Filings

Filed On	Filing
15 Oct 2026	SCHEDULE 13G
09 Sep 2026	Form 4: Schwartz Aharon, Director Granted 17,000 Stock Options (Right to Buy) · Granted 8,500 Restricted Stock Units
04 Sep 2026	Form 4: Elze Christian, Director Granted 17,000 Stock Options (Right to Buy) · Granted 8,500 Restricted Stock Units
04 Sep 2026	Form 4: Naos Yaron, Sr. VP & COO Granted 112,000 Stock Option (Right to Buy) · Granted 56,000 Restricted Stock Units
04 Sep 2026	Form 4: Melincoff Gwen A, Director Granted 17,000 Stock Options (Right to Buy) · Granted 8,500 Restricted Stock Units
04 Sep 2026	Form 4: Boudes Pol F, Director Granted 17,000 Stock Options (Right to Buy) · Granted 8,500 Restricted Stock Units
04 Sep 2026	Form 4: Bashan Dror, Director Granted 320,000 Stock Option (Right to Buy) · Granted 160,000 Restricted Stock Units
04 Sep 2026	Form 4: Bar-Shalev Amos, Director Granted 17,000 Stock Options (Right to Buy) · Granted 8,500 Restricted Stock Units
04 Sep 2026	Form 4: Ben Zvi Shmuel, Director Granted 17,000 Stock Options (Right to Buy) · Granted 8,500 Restricted Stock Units
04 Sep 2026	Form 4: Forster Eliot, Director Granted 17,000 Stock Options (Right to Buy) · Granted 8,500 Restricted Stock Units
12 Aug 2026	FORM S-8
12 Aug 2026	8-K: Results of Operations and Financial Condition
12 Aug 2026	10-Q
29 Jul 2026	SCHEDULE 13G
25 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
21 May 2026	8-K: Regulation FD Disclosure
13 May 2026	8-K: Results of Operations and Financial Condition
13 May 2026	10-Q
30 Apr 2026	ARS
30 Apr 2026	Proxy statement: annual meeting on June 25, 2026 CEO pay $1.2M, down 24% · say-on-pay vote

Comments